Colan Totte.Co.,Ltd.

Business Details

The company's core business is the development and sale of home-use magnetic therapy devices (controlled medical devices) featuring its proprietary "alternating N-pole/S-pole arrangement" technology, deployed through three channels: Wholesale, E-commerce, and Retail. It owns multiple brands including Colantotte, Colantotte RESNO, and Lierrey. Manufacturing is outsourced. Domestic sales account for over 90% of the total, with exports also conducted through sales agents in seven overseas countries. The company also operates a CSS (emergency contact service) business, but given its limited materiality, it is disclosed as a single segment. In the first half of FY2026 (ending March 2026), all three channels performed well, achieving substantial year-on-year increases in both sales and operating profit.

Recent Overview

H1 net sales rose 34.1% year-on-year to ¥4,330 million, with substantial sales growth across all channels.

In the first half of FY2026 (ending March 2026) (October 2025 to March 2026), the company achieved net sales of ¥4,330 million (up 34.1% year-on-year) and operating profit of ¥1,117 million (up 18.2% year-on-year). The E-commerce segment (+72.8%) and Retail segment (+77.5%) showed particularly strong growth. In the Retail segment, four new directly-operated stores were opened during the first half: "AEON MALL Sendai Uesugi," "Mitsui Outlet Park Okazaki," "LaLaport Kadoma," and "Nishinomiya Hankyu." Due to proactive upfront investment in advertising and other measures aimed at expanding brand recognition and promotion, selling, general and administrative expenses increased to ¥1,849 million (up 51.2% year-on-year), causing the operating margin to decline to 25.8% (from 29.3% in the same period of the prior year). Interim net profit increased only 3.3% to ¥768 million, partly due to the effect of an additional recognition of deferred tax assets in the prior-year period. The full-year earnings forecast has been revised upward to net sales of ¥9,000 million and operating profit of ¥2,100 million. The annual dividend forecast is ¥44.00 per share (an increase from ¥42.00 in the prior fiscal year).

Key Products

Growth Drivers

• Strong growth in the E-commerce segment (up 72.8% in H1 of FY2026 ending March 2026): effects of enhanced marketing centered on TV commercials and social media, driving increased brand recognition and successful campaign initiatives
• Expansion of directly-operated stores in the Retail segment (four new stores opened during H1, with an accelerating pace of new openings), diversifying channels and boosting overall sales
• Strong sales of high-value-added products (such as recovery wear) and higher-priced items, expanding the Wholesale segment's mail-order (e-commerce) channel
• Strengthened marketing activities combining TV commercials, newspaper advertisements, social media, and events featuring contracted athletes, driving increased brand recognition
• Enhanced initiatives targeting gift demand (Christmas, Mother's Day, Father's Day), capturing seasonal demand
• Expanding demand driven by growing health consciousness in the sports market

Risks

• Risk that increased SG&A expenses from expanded upfront investment such as advertising (up 51.2% year-on-year in H1 of FY2026 ending March 2026) will continue to pressure profit margins (H1 operating margin declined to 25.8%)
• Rising raw material prices due to yen depreciation (manufacturing is fully outsourced)
• Deterioration in consumer sentiment due to the impact of rising prices and uncertainty over the global economic slowdown and U.S. trade policy
• Risk of sales concentration in the Wholesale segment (approximately 50.5% of H1 net sales)
• Risk of inventory valuation losses (finished goods inventory at the end of H1 increased by ¥179 million compared to the end of the prior fiscal year)
• Increased fixed cost burden from growth in tangible fixed assets (up ¥364 million at the end of H1) associated with new store openings
• Low overseas sales, accounting for less than 10% of total sales, reflecting delayed global expansion